Scott B. Delaney – President and Chief Executive Officer – North America

Scott B. Delaney is Unichem Pharmaceuticals (USA), Inc.’s President and Chief Executive Officer – North America. He is also a member of the Company’s Board of Directors.

Scott is an accomplished leader with over 24 years of experience in brand and generic pharmaceutical management. He brings deep expertise in many areas of generic pharmaceutical management, including sales, marketing, contract negotiation, business development, manufacturing/distribution, third party payor management, product portfolio selection and product life cycle management.

Scott has worked with outstanding organizations such as Eli Lilly and Company, Johnson and Johnson, HEB Grocery Company, Teva Pharmaceuticals, URL Pharma, Cadista Pharmaceuticals, Edenbridge Pharmaceuticals and Heritage Pharmaceuticals, Inc.

Scott earned his B.B.A. in Accounting/MIS from Baylor University and his M.B.A. from the McCombs Graduate School of Business, The University of Texas at Austin.


Rajaram V. Pai – Chief Financial Officer

Rajaram V. Pai is Unichem Pharmaceuticals (USA), Inc’s Chief Financial Officer and is responsible for accounting, finance, forecasting & budgeting, strategic planning, property management, audit and taxes.

Rajaram is a seasoned executive in the generic pharmaceutical industry and has been associated with the Unichem Group for more than 25 years. His areas of expertise include banking, treasury, taxation and finance.

He is a qualified Chartered Accountant from The Institute of Chartered Accountants of India and holds a Bachelor of Commerce (B.Com.) degree from Bombay University.